Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan(Moffitt Cancer Center), Chao Wang(Moffitt Cancer Center), Jamie K. Teer(Moffitt Cancer Center), Eric M. Toloza(Moffitt Cancer Center), Jiqiang Yao(Moffitt Cancer Center), Sungjune Kim(Moffitt Cancer Center), Ana Marie Landin(Moffitt Cancer Center), John E. Mullinax(Moffitt Cancer Center), James J. Saller(Moffitt Cancer Center), Andreas Saltos(Moffitt Cancer Center), David Noyes(Moffitt Cancer Center), Leighann B. Montoya(Moffitt Cancer Center), Wesley Curry(Moffitt Cancer Center), Shari Pilon‐Thomas(Moffitt Cancer Center), Alberto Chiappori(Moffitt Cancer Center), Tawee Tanvetyanon(Moffitt Cancer Center), Frederic J. Kaye(University of Florida), Zachary Thompson(Moffitt Cancer Center), Sean Yoder(Moffitt Cancer Center), Bin Fang(Moffitt Cancer Center), John M. Koomen(Moffitt Cancer Center), Amod A. Sarnaik(Moffitt Cancer Center), Dung‐Tsa Chen(Moffitt Cancer Center), José R. Conejo-García(Moffitt Cancer Center), Eric B. Haura(Moffitt Cancer Center), Scott Antonia(Duke University)
Cited by 418Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis